Robuta

https://theorg.com/org/insilico-medicine Insilico Medicine | The Org insilico medicine https://www.news-medical.net/news/20250225/Insilico-Medicine-reaches-preclinical-milestone-in-MASH-drug-discovery.aspx Insilico Medicine reaches preclinical milestone in MASH drug discovery Feb 25, 2025 - Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently achieved preclinical milestone... insilico medicinereachespreclinicalmilestonemash https://www.globenewswire.com/fr/news-release/2023/05/10/2665618/31533/en/AI-Drug-Discovery-Company-Insilico-Medicine-Offers-Free-Course-on-Target-Identification.html AI Drug Discovery Company Insilico Medicine Offers Free New York, May 10, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced today... ai drug discoveryinsilico medicinecompanyoffersfree https://www.fiercebiotech.com/keyword/insilico-medicine Insilico Medicine | Fierce Biotech insilico medicinefiercebiotech https://www.news-medical.net/news/20170405/Insilico-Medicine-announces-launch-of-intelligently-formulated-nutraceuticals-in-Europe.aspx Insilico Medicine announces launch of intelligently-formulated nutraceuticals in Europe Jun 19, 2019 - Insilico Medicine, Inc, a big data analytics company applying latest advances in deep learning to drug discovery, biomarker development, and aging research... insilico medicineannounceslaunchintelligentlynutraceuticals https://www.news-medical.net/news/20180928/Insilico-Medicine-collaborates-with-MAWI-to-develop-multi-modal-biomarkers-of-aging.aspx Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging Jun 20, 2019 - Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine,... insilico medicineto develop https://www.news-medical.net/news/20260410/Insilico-Medicine-launches-Pharma-AI-Spring-Kickoff-2026-webinar.aspx Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar Apr 10, 2026 - As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and... insilico medicinepharma ailaunchesspringkickoff https://informaconnect.com/lsx-world-congress/speakers/alex-zhavoronkov/ Alex Zhavoronkov - Insilico Medicine | LSX Europe Speaker Join LSX Europe, the leading event for life science and healthcare leaders, in Lisbon, Portugal, on March 25-26, 2026. Designed for early to growth-stage... alex zhavoronkovinsilico medicinelsxeuropespeaker https://www.prnewswire.com/news-releases/insilico-medicine-announces-advancement-of-its-preclinical-candidate-for-usp1-synthetic-lethality-target-to-ind-enabling-studies-for-various-oncological-disorders-301524925.html Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality... /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company today announced that... insilico medicine https://informaconnect.com/lsx-world-congress/speakers/petrina-kamya/ Petrina Kamya - Insilico Medicine | LSX Europe Speaker Join LSX Europe, the leading event for life science and healthcare leaders, in Lisbon, Portugal, on March 25-26, 2026. Designed for early to growth-stage... insilico medicinepetrinakamyalsxeurope https://www.deloitte.com/cn/en/about/press-room/deloitte-china-assists-listing-of-insilico-medicine-on-sehk.html Deloitte China assists listing of InSilico Medicine on SEHK | Deloitte China Deloitte China supported the listing of InSilico Medicine (InSilico Medicine, stock code: 03696.HK) on the Stock Exchange of Hong Kong (SEHK) on 30 December... insilico medicinedeloittechinaassistslisting https://informaconnect.com/investival-showcase-usa/speakers/suguna-rachakonda/ Suguna Rachakonda - Insilico Medicine | LSX Investival Showcase USA Speaker insilico medicinesugunarachakondalsxshowcase https://insilico-medicine-school.teachable.com/ Drug Target Identification | Insilico Medicine School drug targetinsilico medicineidentificationschool https://www.capgemini.com/be-en/insights/expert-perspectives/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery/ Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery - Capgemini... Sep 23, 2025 - Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery insilico medicineai poweredcapgeminipartnering https://www.prnewswire.com/in/news-releases/insilico-medicine-appoints-dr-feng-ren-as-co-ceo-893437678.html Insilico Medicine appoints Dr. Feng Ren as co-CEO Dr. Feng Ren, Chief Scientific Officer (CSO) and head of global research and development is named co-CEO of Insilico Medicine Highlights: Insilico Medicine... insilico medicineappointsdrfengren https://www.prweb.com/releases/leading_computer_scientist_joins_insilico_medicine_s_war_on_aging_and_cancer/prweb11885423.htm Leading Computer Scientist Joins InSilico Medicine's War on Aging and Cancer Baltimore, Maryland (PRWEB) May 28, 2014 -- Today Insilico Medicine, Inc., a Deep Knowledge Ventures' portfolio company based in Baltimore, that is using... war on agingcomputer scientistinsilico medicine https://insilico.com/ Main | Insilico Medicine Generative AI and Automation for Longevity and Sustainability maininsilicomedicine https://www.news-medical.net/news/20231228/Insilico-Medicine-develops-new-AI-generated-FGFR23-inhibitor-for-tissue-agnostic-solid-tumors.aspx Insilico Medicine develops new AI-generated FGFR2/3 inhibitor for tissue-agnostic solid tumors Dec 28, 2023 - Insilico Medicine ("Insilico"), a generative artificial intelligence (AI)-driven clinical-stage drug discovery company, today announced the nomination of... https://www.news-medical.net/news/20240119/Insilico-Medicine-leverages-AI-to-identify-promising-new-target-for-breast-and-gynecological-cancers.aspx Insilico Medicine leverages AI to identify promising new target for breast and gynecological cancers Jan 20, 2024 - Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven drug discovery company, recently published an early research...